VALIDATION IMAGES
A431 cells lysates probed with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:500 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
Paraformaldehyde-fixed and paraffin-embedded Human lung tissue incubated with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human spleen tissue incubated with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human stomach cancer tissue incubated with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
IF(ICC) staining with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:200 in 293T cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:200 in Hela cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Lipocalin-2 (5C9) Monoclonal Antibody (bsm-52914R) at 1:200 in SW480 cells (red). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.